Incorporate new biologic safety data into discussions with your patients with RA.
Explain common insurer reimbursement practices that have arisen in recent years to adapt to rising costs of the treatment of RA.
Discuss the impact of potential future trends in the management of RA such as biologic monotherapy and biosimilars.
1.5 Free CEUs for Nurses
Expires 7/1/15